Table 3

HealthRise screening and diagnosis outputs for programme sites in Brazil, India and South Africa

Data collectionAcross HealthRise sitesBrazilIndiaSouth africa
Teófilo otoniVitória da conquistaUdaipurShimlaPixley ka semeuMgungun-dlovu
 Individuals screened*59 3423129231526 14420 60623664782
 Individuals screened above threshold†643987162683522146771216
 Individuals screened and newly diagnosed146419023326455593129
 Individuals screened*56 6425396360917 99421 48235704591
 Individuals screened above threshold‡256312549983990071129
 Individuals screened and newly diagnosed2954044107562424
  • *Individuals with no previously reported diagnosis of hypertension or diabetes and participated in a HealthRise-supported screening activity.

  • †SBP ≥140 mm Hg or DBP ≥90 mm Hg.

  • ‡Random blood glucose (RBG) measure of ≥140 mg/dL in Vitória da Conquista and both India sites; fasting glucose (FG) ≥126 mg/dL or blood glucose of 200 mg/dL following a glucose tolerance test in both South Africa sites; and a RBG reading of ≥200 mg/dL with at least one classical diabetes symptom (polyuria, polydipsia or polyphagia) or a FG ≥126 mg/dL following a cardiovascular risk assessment (patients with a body mass index ≥25; or age ≥45, or at least moderate cardiovascular disease risk were referred to get a FG test at the health facility) in Teófilo Otoni.

  • DBP, diastolic blood pressure; SBP, systolic blood pressure.